Orphan Drug Designation Approved for Everolimus, Tafamidis Meglumine

The Pharmaceutical Affairs and Food Sanitation Council’s (PAFSC) First Committee on New Drugs approved orphan drug designations for Novartis Pharma’s everolimus (expected indication: tuberous sclerosis complex (TSC)) and Pfizer Japan’s tafamidis meglumine (transthyretin amyloid polyneuropathy (TTR), also known as familial...read more